Clinical Trials List
2013-07-01 - 2015-03-31
Phase II
Terminated4
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- VIN-CENT Wu Division of Nephrology
- SHUEI-LIONG LIN Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 邱鼎育 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Hsi-Hsien Chen Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
1340 participants
